1. Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.
   Paolo Boscolo-Rizzo et al, 2016, Cancer Metastasis Rev CrossRef
2. Exploring the Dynamics of Propeller Loops in Human Telomeric DNA Quadruplexes Using Atomistic Simulations
   Barira Islam et al, 2017, J. Chem. Theory Comput. CrossRef
3. Telomerase reverse transcriptase mutations are independent predictor of disease-free survival in Middle Eastern papillary thyroid cancer
   Rong Bu et al, 2017, Int. J. Cancer CrossRef
4. hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells
   Rishi K. Jaiswal et al, 2018, Molecular Carcinogenesis CrossRef
5. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma.
   Tomonori Sasahira et al, 2018, Int J Mol Sci CrossRef
6. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis
   Ke Yang et al, 2019, Int J Clin Oncol CrossRef
7. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
   A. Prasanth Saraswati et al, 2019, Drug Discovery Today CrossRef
8. TGF‐β‐mediated regulation of plasminogen activators is human telomerase reverse transcriptase dependent in cancer cells
   Rishi K. Jaiswal et al, 2019, BioFactors CrossRef
9. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
   Lizbeth Raju K et al, 2020, Pathol Oncol Res CrossRef
10. Functional and mechanistic analysis of telomerase: An antitumor drug target
    Yinnan Chen et al, 2016, Pharmacology & Therapeutics CrossRef
11. Oral cancer: Deregulated molecular events and their use as biomarkers.
    Nicoleta Sinevici et al, 0 CrossRef
12. Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant
    Elisa Majounie et al, 2020, Cold Spring Harb Mol Case Stud CrossRef
13. Blockade of telomerase reverse transcriptase enhances chemosensitivity in head and neck cancers through inhibition of AKT/ ERK signaling pathways
    Tengda Zhao et al, 2015, Oncotarget CrossRef
14. Telomerase reverse transcriptase interference synergistically promotes tumor necrosis factor‑related apoptosis‑inducing ligand‑induced oral squamous cell carcinoma apoptosis and suppresses proliferation in�vitro and in�vivo
    Xin Zhao et al, 2018, Int J Mol Med CrossRef
15. Exosomal miR‐1255b‐5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial‐to‐mesenchymal transition
    Xue Zhang et al, 2020, Mol Oncol CrossRef
16. Prognostic and Clinicopathological Significance of Telomerase Reverse Transcriptase Upregulation in Oral Cancer: A Systematic Review and Meta-Analysis
    Miguel Ángel González-Moles et al, 2022, Cancers CrossRef
17. Hallmarks of Cancer Expression in Oral Lichen Planus: A Scoping Review of Systematic Reviews and Meta-Analyses
    Miguel Ángel González-Moles et al, 2022, IJMS CrossRef
18. null
    Kannan Ranganathan et al, 2023 CrossRef
19. Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach
    Aamir Amin et al, 2023, Cancers CrossRef
20. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors
    Ioanna Akrida et al, 2023, Med Oncol CrossRef
21. Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives
    Enrico De Lorenzis et al, 2024, Journal of Scleroderma and Related Disorders CrossRef
22. The deregulated physiology in oral squamous cell carcinoma- a brief review
    Keerthika Saravanan et al, 2024, Oral Oncology Reports CrossRef